Joshua Schultz is Senior Vice President & Worldwide Head of PAREXEL Access. Mr. Schultz is responsible for leadership and oversight of all late-stage clinical research, access consulting, drug safety and medical communications activities at PAREXEL. Since joining PAREXEL in 2005, Mr. Schultz has held a number of roles including the Head of the Strategic Partnership group, which focused on developing and executing innovative relationships with key pharmaceutical companies. Mr. Schultz was responsible for building an organization dedicated to efficient operational design and launch of clinical studies and another that focused on pharmacovigilance. Mr. Schultz holds a Master of Philosophy degree in International Relations from the University of Cambridge, U.K, where he was a Thouron Scholar. He also holds a Bachelor of Science in Economics degree from the Wharton School of Business and a Bachelor of Arts degree in International Relations from the University of Pennsylvania. Mr. Schultz has authored several articles and has given numerous presentations at international pharmaceutical industry and biomedical conferences. Prior to joining PAREXEL, Mr. Schultz served as Vice President of Corporate Development at Veritas Medicine, which he co-founded. Previously, he worked at Mercer Management Consulting, where he developed growth strategies for Fortune 500 companies.

Biochemistry, Clinical Research